Chemical Structure : PLX-4545
CAS No.: 2892065-45-9
货号: PC-24555Not For Human Use, Lab Use Only.
PLX-4545 (PLX4545) is a potent and selective, orally bioavailable IKZF2 degrader, that depletes IKZF2 and converts suppressive Tregs into effector-like T-cells leading to antitumor immunity.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥1880 | In stock | |
| 5 mg | ¥3780 | In stock | |
| 10 mg | ¥5780 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PLX-4545 (PLX4545) is a potent and selective, orally bioavailable IKZF2 degrader, that depletes IKZF2 and converts suppressive Tregs into effector-like T-cells leading to antitumor immunity.
Oral administration of PLX-4545 resulted in dose dependent depletion of IKZF2 and single agent antitumor activity in vivo.
PLX-4545 treatment preferentially converted tumor Tregs into effector-like T-cells through decreased CD25 expression and increased production of effector cytokines (IL2, IFNγ), resulting in increased infiltration of CD4/8 Teff cells into tumor tissue.
Combination of PLX-4545 with anti-PD1 significantly increased the proliferation of Teff cells and inhibition of tumor growth in vivo.
| 分子量 | 473.57 | |
| 分子式 | C28H31N3O4 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
(S)-3-(1-oxo-5-(((1S,2S)-2-(3-phenylazetidin-1-yl)cyclohexyl)oxy)isoindolin-2-yl)piperidine-2,6-dione |
|
1. Yujun Huang, et al. Cancer Res (2025) 85 (8_Supplement_1): 6380.
2. Chen Z, et al. Nat Commun. 2025 May 1;16(1):4095.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright